4-Amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide–benzoic acid (1/1)

  title={4-Amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide–benzoic acid (1/1)},
  author={Hadi Arman and Trupta Kaulgud and Edward R. T. Tiekink},
  journal={Acta Crystallographica Section E: Structure Reports Online},
  pages={o2430 - o2430}
The constituents of the title co-crystal, C12H14N4O2S·C7H6O2, are connected by an eight-membered hetero-synthon {⋯NCNH⋯OCOH}, whereby the carboxylic acid forms donor and acceptor hydrogen bonds with a pyrimidine N atom and the adjacent amine, respectively. The dimeric aggregates thus formed are arranged in rows with their terminal NH2 groups forming N—H⋯O hydrogen bonds with neighbouring aggregates to form a two-dimensional array in the ac plane with an overall T-shaped topology. Layers… 

Figures and Tables from this paper

1:1 Co-crystals of sulfadimidine with three bipyridine-type molecules: Persistence of N–H…N hydrogen bonded supramolecular chains
Abstract The crystal and molecular structures of 1:1 cocrystals formed between sulfadimidine and each of three bipyridine-type molecules, namely 4,4′-bipyridine (1), 4-
Differences in Coformer Interactions of the 2,4-Diaminopyrimidines Pyrimethamine and Trimethoprim
The identification and study of supramolecular synthons is a fundamental task in the design of pharmaceutical cocrystals. The malaria drug pyrimethamine (pyr) and the antibiotic trimethoprim (tmp)
Correction: Pharmaceutical crystalline complexes of sulfamethazine with saccharin: same interaction site but different ionization states
Sulfamethazine (SMT), a widely used antibacterial drug, can form either a 1 : 1 salt or a 1 : 1 cocrystal with saccharin (SAC), an artificial sweetener. Interestingly, the two crystalline complexes
Effects of ball-milling and cryomilling on sulfamerazine polymorphs: a quantitative study.
Calibration models were developed for the quantitative analysis of binary (FI/FII, FI/FA, and FII/FA) and ternary mixtures and partial least-squares (PLS) regression to obtain a detailed quantitative picture of solid-state transformations during milling and any subsequent recrystallizations.
Proton-transfer compounds with 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide (sulfamethazine): the structures and hydrogen bonding in the salts with 5-nitrosalicylic acid and picric acid.
The structures of the anhydrous proton-transfer compounds of the sulfa drug sulfamethazine with 5-nitrosalicylic acid and picric acid, namely 2-(4-aminobenzenesulfonamido)-4,6-dimethylpyrimidinium


Benzoic acid–2,9-dimethylphenanthroline (1/1)
The constituents of the title 1:1 co-crystal, C7H6O2·C14H12N2, are connected into dimeric aggregates by a bifurcated O—H⋯N hydrogen bond; the hydroxyl-H atom is hydrogen bonded to the two N atoms of
Molecular complexes of sulfonamides. 2.1:1 complexes between drug molecules: sulfadimidine-acetylsalicylic acid and sulfadimidine-4-aminosalicylic acid
The preparation and crystal structures of the 1:1 complexes sulfadimidine-acetylsalicylic acid (I) and sulfadimidine-4-aminosalicylic acid (II) are described. Each complex unit is maintained by two
Molecular complexes of sulfonamides. Part 1. 1∶1 complexes between sulfadimidine [4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide] and 2- and 4-aminobenzoic acids
The crystal and molecular structures of the 1∶1 complexes sulfadimidine·2-aminobenzoic acid (I) and sulfadimidine·4-aminobenzoic acid (II) are described and compared with known structures containing
Co-crystallization experiments of thiocarbamides with bipyridine-type molecules
Co-crystallization experiments conducted between thiocarbamide derivatives, (E)-O-alkyl N-aryl-thiocarbamide, ROC(S)N(H)R′, for R = Me, Et and iPr, and R′ = Ph and PhNO2-4, containing a
A short history of SHELX.
  • G. Sheldrick
  • Chemistry
    Acta crystallographica. Section A, Foundations of crystallography
  • 2008
This paper could serve as a general literature citation when one or more of the open-source SH ELX programs (and the Bruker AXS version SHELXTL) are employed in the course of a crystal-structure determination.
DIAMOND. Crystal Impact GbR
  • Acta Cryst. E66,
  • 2010
CrystEngComm, 11, 1352–1361
  • Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565. Higashi, T. (1995). ABSCOR. Rigaku Corporation, Tokyo, Japan. Molecular Structure Corporation & Rigaku (2005). CrystalClear. MSC, The
  • 2009
J. Crystallogr. Spectrosc. Res
  • J. Crystallogr. Spectrosc. Res
  • 1991
ABSCOR. Rigaku Corporation
  • ABSCOR. Rigaku Corporation
  • 1995
J. Appl. Cryst.の発刊に際して